US Congress passes omnibus bill, putting synthetic nicotine under FDA jurisdiction

Synthetic nicotine vaping products will likely require the same authorisations as those made with tobacco-derived nicotine – leading to a massive shake-up of the US vaping market.

The change comes after the US Senate and House of Representatives both passed a sweeping $1.5tn omnibus spending bill that will be signed into law by president Joe Biden in the very near future.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ US Congress passes omnibus bill, putting synthetic nicotine under FDA jurisdiction ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ US Congress passes omnibus bill, putting synthetic nicotine under FDA jurisdiction ”






      Synthetic nicotine vaping products will likely require the same authorisations as those made with tobacco-derived nicotine – leading to a massive shake-up of the US vaping market.

      The change comes after the US Senate and House of Representatives both passed a sweeping $1.5tn omnibus spending bill that will be signed into law by president Joe Biden in the very near future.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik